In Medicare Part D Plans, Low Or Zero Copays And Other Features To Encourage The Use Of Generic Statins Work, Could Save Billions

Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug Spending

(2011) M. Christopher Roebuck et al.   HEALTH AFFAIRS

A Value-Based Insurance Design Program At A Large Company Boosted Medication Adherence For Employees With Chronic Illnesses

(2011) Teresa B. Gibson et al.   HEALTH AFFAIRS

Choosing the right medicare prescription drug plan: The effect of age, strategy selection, and choice set size.

(2011) Yaniv Hanoch et al.   HEALTH PSYCHOLOGY

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

(2011) Stephen J. Nicholls et al.   NEW ENGLAND JOURNAL OF MEDICINE

Full Coverage for Preventive Medications after Myocardial Infarction

(2011) Niteesh K. Choudhry et al.   NEW ENGLAND JOURNAL OF MEDICINE

State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid

(2010) William H. Shrank et al.   HEALTH AFFAIRS

Assessing The Evidence For Value-Based Insurance Design

(2010) Niteesh K. Choudhry et al.   HEALTH AFFAIRS

Medicare Beneficiaries' Knowledge of and Choices Regarding Part D, 2005 to the Present

(2010) Jennifer M. Polinski et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Impact of Pharmacy Benefit Design on Prescription Drug Utilization: A Fixed Effects Analysis of Plan Sponsor Data

(2009) M. Christopher Roebuck et al.   HEALTH SERVICES RESEARCH

Impact Of Decreasing Copayments On Medication Adherence Within A Disease Management Environment

(2008) Michael E. Chernew et al.   HEALTH AFFAIRS

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Switching Statin Therapy Using a Pharmacist-Managed Therapeutic Conversion Program versus Usual Care Conversion Among Indigent Patients

(2008) Amy E Miller et al.   PHARMACOTHERAPY